Cargando…

Longitudinal Analysis of the Temporal Evolution of Acinetobacter baumannii Strains in Ohio, USA, by Using Rapid Automated Typing Methods

Genotyping methods are essential to understand the transmission dynamics of Acinetobacter baumannii. We examined the representative genotypes of A. baumannii at different time periods in select locations in Ohio, using two rapid automated typing methods: PCR coupled with electrospray ionization mass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decker, Brooke K., Perez, Federico, Hujer, Andrea M., Hujer, Kristine M., Hall, Geraldine S., Jacobs, Michael R., Gebreyes, Wondwossen A., Zoll, Scott T., Massire, Christian, Eshoo, Mark W., Ecker, David J., Rather, Philip N., Bonomo, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325217/ https://www.ncbi.nlm.nih.gov/pubmed/22511922 http://dx.doi.org/10.1371/journal.pone.0033443

Ejemplares similares

Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA
por: Srinivasan, Vijaya B, et al.
Publicado: (2009)

A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii
por: Hujer, Andrea M., et al.
Publicado: (2021)

New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis
por: Wright, Meredith S., et al.
Publicado: (2014)

Erratum for “New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis”
por: Wright, Meredith S., et al.
Publicado: (2015)

Draft Genome Sequence of the Clinical Isolate Acinetobacter nosocomialis Strain M2
por: Carruthers, Michael D., et al.
Publicado: (2013)

687. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Acinetobacter spp.
por: Goldberg, Joel, et al.
Publicado: (2019)

Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii
por: Introvigne, Maria Luisa, et al.
Publicado: (2023)

Are Staphylococcus intermedius Infections in Humans Cases of Mistaken Identity? A Case Series and Literature Review
por: Viau, Roberto, et al.
Publicado: (2015)

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis
por: Lin, Lin, et al.
Publicado: (2012)

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
por: Barnes, Melissa D., et al.
Publicado: (2019)

Transcriptome Remodeling of Acinetobacter baumannii during Infection and Treatment
por: Wright, Meredith S., et al.
Publicado: (2017)

Multidrug-resistant Acinetobacter pittii is adapting to and exhibiting potential succession aboard the International Space Station
por: Tierney, Braden T., et al.
Publicado: (2022)

Multidrug Resistant Pseudomonas aeruginosa Causing Prosthetic Valve Endocarditis: A Genetic-Based Chronicle of Evolving Antibiotic Resistance
por: Domitrovic, T. Nicholas, et al.
Publicado: (2016)

Advances in automated techniques to identify Acinetobacter calcoaceticus–Acinetobacter baumannii complex
por: Bagudo, Ahmad Ibrahim, et al.
Publicado: (2020)

609. Differing Genotypic Contexts Between E. coli and A. baumannii Modulate the Role of blaADC-7 in the Development of Antibiotic Collateral Sensitivity
por: McClure, Erin, et al.
Publicado: (2019)

Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075
por: Anderson, Sarah E., et al.
Publicado: (2018)

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
por: Wright, Meredith S., et al.
Publicado: (2016)

698. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Multidrug-Resistant Gram-Negative Bacilli
por: Goldberg, Joel, et al.
Publicado: (2019)

608 Can Rapid Molecular Diagnostics Assist in the Choice of b-Lactam Antibiotics? An Analysis of Data from PRIMERS-II of the Antibiotic Resistance Leadership Group (ARLG)
por: Hujer, Andrea M., et al.
Publicado: (2014)

Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis
por: Colquhoun, Jennifer M., et al.
Publicado: (2020)

Collateral Changes in Cell Physiology Associated with ADC-7 β-Lactamase Expression in Acinetobacter baumannii
por: Colquhoun, Jennifer M., et al.
Publicado: (2023)

1351. In vitro Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, Against Enterobacteriaceae With Defined Extended-Spectrum Β-Lactamases and Carbapenemases
por: Jacobs, Michael R, et al.
Publicado: (2018)

Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum
por: Powers, Rachel A., et al.
Publicado: (2023)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA
por: Yassin, Mohamed H., et al.
Publicado: (2020)

OXA-23 β-Lactamase Overexpression in Acinetobacter baumannii Drives Physiological Changes Resulting in New Genetic Vulnerabilities
por: Colquhoun, Jennifer M., et al.
Publicado: (2021)

Natural history of Acinetobacter baumannii infection in mice
por: Luna, Brian M., et al.
Publicado: (2019)

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
por: Ramirez, Maria Soledad, et al.
Publicado: (2020)

Carbapenem-Resistant Enterobacter cloacae Isolates Producing KPC-3, North Dakota, USA
por: Kiedrowski, Lee M., et al.
Publicado: (2014)

1348. In vitro Activity of Plazomicin, a Next-Generation Aminoglycoside, Against Carbapenemase-Producing Klebsiella pneumoniae
por: Jacobs, Michael R, et al.
Publicado: (2018)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

1256. In Vivo Activity and Structural Characterization of a New Generation γ-Lactam Siderophore Antibiotic Against Multidrug-Resistant Gram-Negative Bacteria and Acinetobacter spp
por: Goldberg, Joel, et al.
Publicado: (2020)

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

Ibis T5000: a universal biosensor approach for microbiology
por: Ecker, David J., et al.
Publicado: (2008)

Multiple roles for a novel RND‐type efflux system in Acinetobacter baumannii AB5075
por: Tipton, Kyle A., et al.
Publicado: (2016)

Database for the ampC alleles in Acinetobacter baumannii
por: Karah, Nabil, et al.
Publicado: (2017)

Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections
por: Watkins, Richard R, et al.
Publicado: (2023)

A LysR-Type Transcriptional Regulator Controls Multiple Phenotypes in Acinetobacter baumannii
por: Tierney, Aimee R. P., et al.
Publicado: (2021)

Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire
por: Adams, Mark D., et al.
Publicado: (2019)

971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
por: Nielsen, Travis B, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bmcenmirc9e1ofvrj6ugb0tnca